دورية أكاديمية
Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics.
| العنوان: | Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics. |
|---|---|
| المؤلفون: | Jayne, David R. W., Terrier, Benjamin, Hellmich, Bernhard, Khoury, Paneez, Baylis, Lee, Bentley, Jane H., Steinfeld, Jonathan, Yancey, Steven W., Kwon, Namhee, Wechsler, Michael E., Akuthota, Praveen |
| المصدر: | ERJ Open Research; Jan2024, Vol. 10 Issue 1, p1-12, 12p |
| قاعدة البيانات: | Complementary Index |
Full Text Finder | تدمد: | 23120541 |
|---|---|
| DOI: | 10.1183/23120541.00509-2023 |